John Markels

John Markels

Director/Board Member at SANGAMO THERAPEUTICS, INC.

Net worth: 21 012 $ as of 30/05/2026

60 year
Health Technology
Consumer Services

Profile

John H.
Markels
is currently an Independent Director at Sangamo Therapeutics, Inc. since 2020.
Dr. Markels is also a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. Additionally, Dr. Markels serves as an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Dr. Markels earned a doctorate from the University of California, Berkeley and completed undergraduate studies at the University of Delaware.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/06/2025 96,384 ( 0.02% ) 21 012 $ 30/05/2026
04/06/2026 0 ( -.--% ) - $ 30/05/2026

John Markels active positions

CompaniesPositionStart
SANGAMO THERAPEUTICS, INC. Director/Board Member 10/02/2020
ARCTURUS THERAPEUTICS HOLDINGS INC. Director/Board Member 07/12/2022
Director/Board Member -
Director/Board Member -

Former positions of John Markels

CompaniesPositionEnd
MERCK & CO., INC. Corporate Officer/Principal 28/02/2022
See the detail of John Markels's experience

Training of John Markels

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!